Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
| ▸ | CCR2 | P41597 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11033316 | 0.72 | ALDH1A1 (0.39) | ALDH1A1TSHR | |
| SCHEMBL2129176 | 0.70 | KEAP1 (0.36) | ALDH1A1CASP1TSHRCCR2 | |
| SCHEMBL27826766 | 0.70 | EPHX1 (0.35) | EPHX1 | |
| SCHEMBL820423 | 0.69 | EPHX1 (0.40) | ALDH1A1EPHX1CCR2GAA | |
| SCHEMBL28004359 | 0.68 | EPHX1 (0.36) | EPHX1CCR2 | |
| SCHEMBL5510657 | 0.68 | EPHX1 (0.38) | EPHX1 | |
| SCHEMBL28558883 | 0.67 | CYP19A1 (0.43) | ALDH1A1EPHX1CCR2 | |
| SCHEMBL6253845 | 0.66 | L3MBTL1 (0.36) | ALDH1A1TSHREPHX1 | |
| SCHEMBL1410774 | 0.66 | GRM2 (0.41) | ALDH1A1TSHRCCR2 | |
| SCHEMBL432459 | 0.66 | CCR2 (0.37) | ALDH1A1TSHREPHX1CCR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3684898-B1 | METHOD FOR PRODUCING AN ACTIVE SUBSTANCE WAFER | SYMRISE AG (DE) | 2025-04-30 | — | — | EP | disclosed |
| US-20220411728-A1 | HOME CARE PRODUCT OR FORMULATION | SYMRISE AG (DE) | 2022-12-29 | — | — | US | disclosed |
| US-11512267-B2 | Active substance wafer | SYMRISE AG (DE) | 2022-11-29 | — | — | US | disclosed |
| EP-4061915-A1 | HOME CARE PRODUCT OR FORMULATION | Symrise AG (DE) | 2022-09-28 | — | — | EP | disclosed |
| CN-114585715-A | Home care products or formulations | 西姆莱斯有限公司 | 2022-06-03 | — | — | CN | disclosed |
| WO-2021098950-A1 | HOME CARE PRODUCT OR FORMULATION | SYMRISE AG (DE) | 2021-05-27 | — | — | WO | disclosed |
| EP-3740556-A1 | TRANSPARENT ACTIVE SUBSTANCE RELEASE COMPOSITION AND METHOD FOR PRODUCING THE SAME | Symrise AG (DE) | 2020-11-25 | — | — | EP | disclosed |
| EP-3737427-A1 | ARTICLE WITH SEPARATING LAYER FOR CONTROLLED RELEASE OF FRAGRANCES | Symrise AG (DE) | 2020-11-18 | — | — | EP | disclosed |
| EP-3737428-A1 | ARTICLE PROVIDING SELECTIVE INTERCONNECTIVITY OF CARRIER MATERIALS COMPRISING FRAGRANCES | Symrise AG (DE) | 2020-11-18 | — | — | EP | disclosed |
| EP-3684898-A1 | ACTIVE SUBSTANCE WAFER | Symrise AG (DE) | 2020-07-29 | — | — | EP | disclosed |
| US-20200216782-A1 | ACTIVE SUBSTANCE WAFER | SYMRISE AG (DE) | 2020-07-09 | — | — | US | disclosed |
| WO-2019057294-A1 | ACTIVE SUBSTANCE WAFER | SYMRISE AG (DE) | 2019-03-28 | — | — | WO | disclosed |
| EP-2336418-B1 | Cavity containing odorous substances consisting of a polymer matrix | SYMRISE AG (DE) | 2013-08-28 | — | — | EP | disclosed |
| US-8513180-B2 | Ethanol-free perfume oil microemulsion | SYMRISE AG (DE) | 2013-08-20 | — | — | US | disclosed |
| EP-2316408-B1 | Ethanol-free perfume oil microemulsion | SYMRISE AG (DE) | 2013-07-03 | — | — | EP | disclosed |
| US-20120101020-A1 | ETHANOL-FREE PERFUME OIL MICROEMULSION | SYMRISE AG (DE) | 2012-04-26 | — | — | US | disclosed |
| EP-2336418-A1 | Cavity containing odorous substances consisting of a polymer matrix | Symrise AG (DE) | 2011-06-22 | — | — | EP | disclosed |
| EP-2316408-A1 | Ethanol-free perfume oil microemulsion | Symrise AG (DE) | 2011-05-04 | — | — | EP | disclosed |
| EP-2031047-A1 | Body and powder mixture for releasing CO2 | Symrise GmbH & Co. KG (DE) | 2009-03-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120101020-A1 | ETHANOL-FREE PERFUME OIL MICROEMULSION | FFAR2, FFAR3, FFAR1 | ALDH1A1 226/4885CASP1 2563/4885TSHR 4260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.